Daxor/$DXR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Daxor
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Ticker
$DXR
Sector
Primary listing
Employees
45
Headquarters
Website
Daxor Metrics
BasicAdvanced
$58M
32.28
$0.36
-0.10
-
Price and volume
Market cap
$58M
Beta
-0.1
52-week high
$11.70
52-week low
$7.10
Average daily volume
55K
Financial strength
Current ratio
1.211
Quick ratio
0.191
Long term debt to equity
0.738
Total debt to equity
0.738
Interest coverage (TTM)
-27.82%
Profitability
Gross margin (TTM)
100.00%
Net profit margin (TTM)
2,710.84%
Operating margin (TTM)
-2,131.07%
Management effectiveness
Return on assets (TTM)
-2.51%
Return on equity (TTM)
5.26%
Valuation
Price to earnings (TTM)
32.279
Price to revenue (TTM)
875.056
Price to book
1.63
Price to tangible book (TTM)
1.63
Price to free cash flow (TTM)
41.839
Free cash flow yield (TTM)
2.39%
Free cash flow per share (TTM)
0.278
Growth
Revenue change (TTM)
-57.00%
Earnings per share change (TTM)
3.46%
3-year revenue growth (CAGR)
-38.69%
10-year revenue growth (CAGR)
-26.74%
3-year earnings per share growth (CAGR)
-31.25%
10-year earnings per share growth (CAGR)
-11.89%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Daxor stock?
Daxor (DXR) has a market cap of $58M as of September 16, 2025.
What is the P/E ratio for Daxor stock?
The price to earnings (P/E) ratio for Daxor (DXR) stock is 32.28 as of September 16, 2025.
Does Daxor stock pay dividends?
No, Daxor (DXR) stock does not pay dividends to its shareholders as of September 16, 2025.
When is the next Daxor dividend payment date?
Daxor (DXR) stock does not pay dividends to its shareholders.
What is the beta indicator for Daxor?
Daxor (DXR) has a beta rating of -0.1. This means that it has an inverse relation to market volatility.